These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2529742)

  • 21. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease.
    Welch AM; Holda JH; Swanborg RH
    J Immunol; 1980 Jul; 125(1):186-9. PubMed ID: 6155396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulatory azaspirane, SK&F 106610.
    Rabinovitch A; Suarez WL; Qin HY; Power RF; Badger AM
    J Autoimmun; 1993 Feb; 6(1):39-49. PubMed ID: 8457285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.
    Taylor AW; Kitaichi N
    Brain Behav Immun; 2008 Jul; 22(5):639-46. PubMed ID: 18171609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
    Killen JA; Swanborg RH
    J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological activities of spirogermanium and other structurally related azaspiranes: effects on tumor cell and macrophage functions.
    Mirabelli CK; Badger AM; Sung CP; Hillegass L; Sung CM; Johnson RK; Picker D; Schwartz D; Dorman J; Martellucci S
    Anticancer Drug Des; 1989 Mar; 3(4):231-42. PubMed ID: 2930625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune effector cells. II. Transfer of experimental allergic encephalomyelitis with a subset of T lymphocytes.
    Holda JH; Swanborg RH
    Eur J Immunol; 1982 May; 12(5):453-5. PubMed ID: 6980130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis.
    Kumar V; Aziz F; Sercarz E; Miller A
    J Exp Med; 1997 May; 185(10):1725-33. PubMed ID: 9151697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.
    Suszko A; Obmińska-Mrukowicz B
    J Ethnopharmacol; 2013 Jan; 145(1):109-17. PubMed ID: 23123796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoration of diminished splenic responses to phytohemagglutinin and concanavalin A in adjuvant-induced disease by virazole: possible pathogenetic role of a virus and suppressor cells.
    Kapusta MH; Young-Rodenchuk M; Kourounakis L
    J Rheumatol; 1979; 6(5):507-18. PubMed ID: 160459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CII-specific autoimmune T-cell response develops in the presence of FTY720 but is regulated by enhanced Treg cells that inhibit the development of autoimmune arthritis.
    Miller DC; Whittington KB; Brand DD; Hasty KA; Rosloniec EF
    Arthritis Res Ther; 2016 Jan; 18():8. PubMed ID: 26757712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitro.
    Hill BT; Whatley SA; Bellamy AS; Jenkins LY; Whelan RD
    Cancer Res; 1982 Jul; 42(7):2852-6. PubMed ID: 7200828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The autologous mixed lymphocyte reaction is decreased in Freund's adjuvant-injected rats of arthritis-susceptible and -insusceptible strains.
    Crowe WE; Battisto JR; Smith RN
    Arthritis Rheum; 1985 May; 28(5):537-41. PubMed ID: 3159391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo immunopharmacological profile of Sch 40120.
    Smith SR; Watnick AS; Kung T; Siegel MI
    Immunopharmacol Immunotoxicol; 1993 Jan; 15(1):13-44. PubMed ID: 8450179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of spirogermanium on the in vitro assembly and disassembly of brain microtubules.
    Peyrot V; Briand C; Codaccioni F; Sari JC
    Chem Biol Interact; 1987 Feb; 61(2):151-8. PubMed ID: 3829141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis.
    Lange F; Bajtner E; Rintisch C; Nandakumar KS; Sack U; Holmdahl R
    Ann Rheum Dis; 2005 Apr; 64(4):599-605. PubMed ID: 15345503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugs.
    Hill BT; Whelan RD
    Invest New Drugs; 1986; 4(4):359-65. PubMed ID: 3583643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural suppressor (NS) cells found in the spleen of neonatal mice and adult mice given total lymphoid irradiation (TLI) express the null surface phenotype.
    Oseroff A; Okada S; Strober S
    J Immunol; 1984 Jan; 132(1):101-10. PubMed ID: 6228575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.
    al-Sabbagh A; Nelson PA; Akselband Y; Sobel RA; Weiner HL
    Cell Immunol; 1996 Jul; 171(1):111-9. PubMed ID: 8660845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A partial characterization of suppressor cells in the spleens of mice conditioned with fractionated total lymphoid irradiation (TLI).
    May RD; Slavin S; Vitetta ES
    J Immunol; 1983 Sep; 131(3):1108-14. PubMed ID: 6224848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins.
    Lider O; Baharav E; Mekori YA; Miller T; Naparstek Y; Vlodavsky I; Cohen IR
    J Clin Invest; 1989 Mar; 83(3):752-6. PubMed ID: 2493485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.